ESC Premium Access

Poster session 1 - Treatment of hypertension

Event: ESC CONGRESS 2016
Topic: Miscellaneous
Session type: Poster Session
Date: 27 August 2016

Congress Session

11 presentations in this session

A novel approach to perform renal sympathetic denervation in moderate to severe chronic kidney disease using carbon dioxide angiography

Speaker: Doctor M. Hameed (Birmingham, GB)
Thumbnail

Results from real-world evidence and randomized controlled clinical studies with the combination of amlodipine and valsartan

Speaker: Doctor P. Brunel (Basel, CH)
Thumbnail

Statins and perindopril\amlodipine efficacy in hypertensive patients with hypercholesterolemia

Speaker: Professor G. Radchenko (Kyiv, UA)
Thumbnail

Poor control of blood pressure is associated with increased risk of cardiovascular events in hypertensive patients with atherosclerotic vascular diseases, especially in the elderly

Speaker: Associate Professor W. Chang (Taipei, TW)
Thumbnail

Factors that exacerbate resistance to the antihypertensive treatment in hypertensive patients with diabetes

Speaker: Professor Y. Dohi (Nagoya, JP)
Thumbnail

Is ARB/CCB combination superior to ARB/HCTZ combination in day-by-day blood pressure variability reduction? a prospective randomized trial

Speaker: Professor H. Kai (Kurume, JP)
Thumbnail

Effectiveness of perindopril/amlodipine fixed dose combination in hypertensive patients with coronary artery disease. A panhellenic prospective non-interventional study.

Speaker: Doctor M. Kallistratos (Voula, GR)
Thumbnail

Effect of algorithmized antihypertensive treatment at masked uncontrolled hypertension persistence in uncomplicated hypertensives

Speaker: Professor K. Amosova (Kyiv, UA)
Thumbnail

Efficacy,safety and treatment adherence with fixed-combination perindopril arginine/amlodipine in patients switched from previous ineffective free combination antihypertensive therapy in real practice

Speaker: Professor M. Glezer (Moscow, RU)
Thumbnail

Comparison between canrenone or hydrochlorothiazide in addition to sartans in hypertensive diabetic patients

Speaker: Professor G. Derosa (Pavia, IT)
Thumbnail

11 speakers from this session

Doctor Mohammed Hameed

Heart of England NHS Foundation Trust, Birmingham (United Kingdom of Great Britain & Northern Ireland)
0 follower

Doctor Patrick Brunel

, Basel (Switzerland)
0 follower

Professor Ganna Radchenko

Institute of Cardiology, Kyiv (Ukraine)
1 presentation
0 follower

Associate Professor Wei-Tien Chang

National Taiwan University Hospital, Department of Internal Medicine, Taipei (Taiwan)
0 follower

Professor Yasuaki Dohi

Nagoya Gakukin University, Nagoya (Japan)
0 follower

Professor Hisashi Kai

Kurume University Medical Center, Kurume (Japan)
0 follower

Doctor Manolis Kallistratos

Asklipieio Voulas Hospital, Voula (Greece)
0 follower

Professor Kateryna Amosova

O. O . Bogomolets National Medical University, Kyiv (Ukraine)
0 follower

Professor Maria Glezer

I.M. Sechenov First Moscow State Medical University, Moscow (Russian Federation)
0 follower

Professor Giuseppe Derosa

University of Pavia, Pavia (Italy)
0 follower

Professor Aleksandra Konradi

Almazov Federal Medical Research Centre, Saint-Petersburg (Russian Federation)
7 presentations
0 follower

This platform is supported by

logo Novo Nordisk